FC25: Illuminate the Role of IL-13 Inhibitors for the Management of Atopic Dermatitis: An Online Activity

Don’t miss this Satellite Symposium from the 2025 Fall Clinical Dermatology Conference®, as Dr. Alexandra Golant, Dr. Mona Shahriari, and Dr. G. Michael Lewitt discuss IL-13 targeting biologics in the treatment of atopic dermatitis as well as strategies for optimizing their use.

“To me, coming into an exam room in 2025, when we have so many different treatment options for these patients, it's a unique opportunity to use what we know about the data of these therapeutics and walk patients though their options and how to understand their disease state, and how to best choose the therapy that feels right for them.” – Alexandra Golant, MD  

FC25: Illuminate the Role of IL-13 Inhibitors for the Management of Atopic Dermatitis

This activity is supported by an educational grant from Lilly.